Kailera Therapeutics, Inc. (KLRA)

NASDAQ: KLRA · Real-Time Price · USD

14.84

-1.59 (-9.68%)

At close: Sep 9, 2026, 4:00 PM EDT

14.84

0.00 (0.00%)

After-hours: Sep 9, 2026, 4:27 PM EDT

Kailera Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-313.27	-158.34	-24.52
Net Income	-292.2	-148.96	-329.57
Earnings Per Share	-2.25	-7819.98	-
EPS Growth	-	-	-

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	1,172	652.73	175.18
Total Debt	10.22	10.75	0.51
Net Cash (Debt)	1,162	641.98	174.67
Net Cash Growth	-	267.54%	-
Net Cash Per Share	8.96	33703.01	-

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-221.62	-120.21	-184.95
Capital Expenditures	-2.09	-2.09	-0.39
Free Cash Flow	-223.7	-122.3	-185.35
Free Cash Flow Growth	-	-	-